Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof

Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof

US Patent 5554724 · Granted Sep 10, 1996

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B vi2021
Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B vi2019
Peptides, conjugates and method for increasing immunogenicity of a vaccine2016
Monophenols and benzenediols sensitization of immune system against haptenized m2016
HLA binding motifs and peptides and their uses2016
Method for modulating activity of T lymphocytes2015
Method for modulating activity of T lymphocytes2015
Tumour rejection antigens2013
Detection of individual T-cell reaction patterns against tumor-associated antige2013
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof2012
Tumor associated amino acids and uses therefor2012
MAGE-C2 antigenic peptides and uses thereof2012